Adenovirus Vectors For Gene Therapy Sponsorship


Ontology type: sgo:Patent     


Patent Info

DATE

1996-05-08T00:00

AUTHORS

ENGELHARDT, JOHN , WILSON, JAMES M.

ABSTRACT

The present invention comprises an improved adenovirus vector and methods for making and using such vectors. The adenovirus vectors of the present invention retain at least a portion of the adenoviral E3 region, carry a deletion of at least a portion of the adenoviral E1 region. Vectors of the present invention preferably also include an additional deletion to accommodate a transgene and/or other mutations which result in reduced expression or over-expression of adenoviral protein and/or reduced viral replication. The vectors of the present invention further include a transgene operatively-linked thereto. By reducing or eliminating viral replication and viral protein expression, the immune response of the infected host to the virus and viral protein is decreased and persistence of transgene expression can be increased. The adenovirus vectors of the present invention are thus particularly useful in gene transfer and therapy. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2995", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "ENGELHARDT, JOHN", 
        "type": "Person"
      }, 
      {
        "name": "WILSON, JAMES M.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ng0794-362", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001773368", 
          "https://doi.org/10.1038/ng0794-362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0593-27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010312039", 
          "https://doi.org/10.1038/ng0593-27"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.13.6196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019406962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci116175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047944843"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1996-05-08T00:00", 
    "description": "

The present invention comprises an improved adenovirus vector and methods for making and using such vectors. The adenovirus vectors of the present invention retain at least a portion of the adenoviral E3 region, carry a deletion of at least a portion of the adenoviral E1 region. Vectors of the present invention preferably also include an additional deletion to accommodate a transgene and/or other mutations which result in reduced expression or over-expression of adenoviral protein and/or reduced viral replication. The vectors of the present invention further include a transgene operatively-linked thereto. By reducing or eliminating viral replication and viral protein expression, the immune response of the infected host to the virus and viral protein is decreased and persistence of transgene expression can be increased. The adenovirus vectors of the present invention are thus particularly useful in gene transfer and therapy.

", "id": "sg:patent.EP-0710123-A1", "keywords": [ "adenovirus vector", "invention", "method", "vector", "portion", "E3", "deletion", "E1", "transgene", "mutation", "reduced expression", "over-expression", "protein", "viral replication", "viral protein expression", "immune response", "infected host", "virus", "viral protein", "persistence", "transgene expression", "gene transfer", "therapy" ], "name": "ADENOVIRUS VECTORS FOR GENE THERAPY SPONSORSHIP", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.214458.e", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-0710123-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:24", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_02163.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-0710123-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-0710123-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-0710123-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-0710123-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

63 TRIPLES      15 PREDICATES      41 URIs      31 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-0710123-A1 schema:about anzsrc-for:2995
2 schema:author N9b33a268ec244e0eaf13314531b7696e
3 schema:citation sg:pub.10.1038/ng0593-27
4 sg:pub.10.1038/ng0794-362
5 https://doi.org/10.1073/pnas.91.13.6196
6 https://doi.org/10.1172/jci116175
7 schema:datePublished 1996-05-08T00:00
8 schema:description <p>The present invention comprises an improved adenovirus vector and methods for making and using such vectors. The adenovirus vectors of the present invention retain at least a portion of the adenoviral E3 region, carry a deletion of at least a portion of the adenoviral E1 region. Vectors of the present invention preferably also include an additional deletion to accommodate a transgene and/or other mutations which result in reduced expression or over-expression of adenoviral protein and/or reduced viral replication. The vectors of the present invention further include a transgene operatively-linked thereto. By reducing or eliminating viral replication and viral protein expression, the immune response of the infected host to the virus and viral protein is decreased and persistence of transgene expression can be increased. The adenovirus vectors of the present invention are thus particularly useful in gene transfer and therapy.</p>
9 schema:keywords E1
10 E3
11 adenovirus vector
12 deletion
13 gene transfer
14 immune response
15 infected host
16 invention
17 method
18 mutation
19 over-expression
20 persistence
21 portion
22 protein
23 reduced expression
24 therapy
25 transgene
26 transgene expression
27 vector
28 viral protein
29 viral protein expression
30 viral replication
31 virus
32 schema:name ADENOVIRUS VECTORS FOR GENE THERAPY SPONSORSHIP
33 schema:recipient https://www.grid.ac/institutes/grid.214458.e
34 schema:sameAs https://app.dimensions.ai/details/patent/EP-0710123-A1
35 schema:sdDatePublished 2019-04-18T10:24
36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
37 schema:sdPublisher Nba0fa80c36c14e2fbaa06012124259dd
38 sgo:license sg:explorer/license/
39 sgo:sdDataset patents
40 rdf:type sgo:Patent
41 N135672ead2bd4f26a5771552ee9b8137 schema:name ENGELHARDT, JOHN
42 rdf:type schema:Person
43 N84b1722ee34c4275933922142a639711 schema:name WILSON, JAMES M.
44 rdf:type schema:Person
45 N9b33a268ec244e0eaf13314531b7696e rdf:first N135672ead2bd4f26a5771552ee9b8137
46 rdf:rest Nc61c68192d2e4bbda8e8a52db06f33e7
47 Nba0fa80c36c14e2fbaa06012124259dd schema:name Springer Nature - SN SciGraph project
48 rdf:type schema:Organization
49 Nc61c68192d2e4bbda8e8a52db06f33e7 rdf:first N84b1722ee34c4275933922142a639711
50 rdf:rest rdf:nil
51 anzsrc-for:2995 schema:inDefinedTermSet anzsrc-for:
52 rdf:type schema:DefinedTerm
53 sg:pub.10.1038/ng0593-27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010312039
54 https://doi.org/10.1038/ng0593-27
55 rdf:type schema:CreativeWork
56 sg:pub.10.1038/ng0794-362 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001773368
57 https://doi.org/10.1038/ng0794-362
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1073/pnas.91.13.6196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019406962
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1172/jci116175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047944843
62 rdf:type schema:CreativeWork
63 https://www.grid.ac/institutes/grid.214458.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...